Netherlands· NL-0e3f91f1f9a8
Tenofovirdisoproxil Viatris 245 mg, filmomhulde tabletten
A tenofovir disoproxil product containing tenofovirdisoproxilmaleaat, registered in Netherlands by Viatris Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tenofovir disoproxil is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AF07 (tenofovir disoproxil), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tenofovir disoproxil · ATC J05AF07
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tenofovir disoproxil costs, country by country.
Normalised to the WHO defined daily dose (0.245 g), the median price runs from $0.24 in United States to $14.17 in Switzerland — a ×59 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Tenofovir disoproxil · price per daily dose (0.245 g)
USD · FX 28 Sept 2026
- CH Switzerland$14.17
- FR France$4.15
- US United States$0.24 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TENOFOVIRDISOPROXILMALEAAT
- Manufacturer
- Viatris Limited
- Country
- Netherlands (NL)
- ATC code
- J05AF07
- ATC class
- Tenofovir disoproxil
- Defined daily dose
- 0.245 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/16/1129
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for tenofovir disoproxil.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tenofovir disoproxil · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J05AF07
Tenofovir disoproxil, as other registers publish it.
- CanadaAG-TENOFOVIRANGITA PHARMA INC.
- CanadaAPO-TENOFOVIRAPOTEX INC
- CanadaAURO-TENOFOVIRAURO PHARMA INC
- FinlandIctadySanoSwiss UAB
- CanadaJAMP-TENOFOVIRJAMP PHARMA CORPORATION
- CanadaMINT-TENOFOVIRMINT PHARMACEUTICALS INC
- CanadaMYLAN-TENOFOVIR DISOPROXILMYLAN PHARMACEUTICALS ULC
- CanadaNAT-TENOFOVIRNATCO PHARMA (CANADA) INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff8c6f7c-944d-4e5b-89de-254fc7cc8f2f GET /v1/drugs/ff8c6f7c-944d-4e5b-89de-254fc7cc8f2f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tenofovir-disoproxil-viatris-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Tenofovir Disoproxil",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp117865",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"GLYCEROLTRIACETAAT (E 1518)",
"HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"INDIGOKARMIJN ALUMINIUMLAK (E 132)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"TENOFOVIRDISOPROXILMALEAAT"
],
"leaflet_url": null,
"authorised_at": "2016/12/08",
"procedure_number": "EMEA/H/C/004049",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/16/1129",
"additional_monitoring": "N"
}See everything about tenofovir disoproxil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.